{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dalteparin&page=6", "query": { "intervention": "Dalteparin", "page": 6 }, "page_size": 10 }, "pagination": { "page": 6, "page_size": 10, "total_count": 205, "total_pages": 21, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dalteparin&page=7&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dalteparin&page=5&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-17T15:01:04.828Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06243510", "title": "Comparison of Apixaban Versus Enoxaparin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bladder Cancer" ], "interventions": [ { "name": "apixaban", "type": "OTHER" }, { "name": "enoxaparin", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Abramson Cancer Center at Penn Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 126, "start_date": "2023-11-24", "completion_date": "2026-03-30", "has_results": false, "last_update_posted_date": "2026-06-23", "last_synced_at": "2026-10-17T15:01:04.828Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06243510" }, { "nct_id": "NCT00311090", "title": "Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Deep Venous Thrombosis" ], "interventions": [ { "name": "Idrabiotaparinux sodium", "type": "DRUG" }, { "name": "Idraparinux sodium", "type": "DRUG" }, { "name": "Avidin", "type": "DRUG" }, { "name": "Placebo (for Avidin)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 757, "start_date": "2006-04", "completion_date": "2008-01", "has_results": false, "last_update_posted_date": "2016-03-21", "last_synced_at": "2026-10-17T15:01:04.828Z", "location_count": 1, "location_summary": "Bridgewater, New Jersey", "locations": [ { "city": "Bridgewater", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00311090" }, { "nct_id": "NCT04829552", "title": "Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Covid19" ], "interventions": [], "intervention_types": [], "sponsor": "Corewell Health East", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 704, "start_date": "2020-03-10", "completion_date": "2020-04-15", "has_results": false, "last_update_posted_date": "2021-04-02", "last_synced_at": "2026-10-17T15:01:04.828Z", "location_count": 1, "location_summary": "Royal Oak, Michigan", "locations": [ { "city": "Royal Oak", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT04829552" }, { "nct_id": "NCT01042704", "title": "Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Myeloma" ], "interventions": [ { "name": "Bendamustine", "type": "DRUG" }, { "name": "Lenalidomide", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Aspirin", "type": "DRUG" }, { "name": "Prophylaxis", "type": "DRUG" }, { "name": "Antibiotic", "type": "DRUG" }, { "name": "Biweekly Follow Up", "type": "OTHER" }, { "name": "Cyclical Follow Up", "type": "OTHER" }, { "name": "Restaging", "type": "OTHER" }, { "name": "Post-Treatment Follow Up", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Robert Redner, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 29, "start_date": "2008-02", "completion_date": "2015-03", "has_results": false, "last_update_posted_date": "2017-07-31", "last_synced_at": "2026-10-17T15:01:04.828Z", "location_count": 22, "location_summary": "Detroit, Michigan • Steubenville, Ohio • Beaver, Pennsylvania + 13 more", "locations": [ { "city": "Detroit", "state": "Michigan" }, { "city": "Steubenville", "state": "Ohio" }, { "city": "Beaver", "state": "Pennsylvania" }, { "city": "Clairton", "state": "Pennsylvania" }, { "city": "Greensburg", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01042704" }, { "nct_id": "NCT04305756", "title": "Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Thromboembolism", "Postpartum DVT", "Thrombosis" ], "interventions": [ { "name": "Enoxaparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "FEMALE", "summary": "18 Years to 55 Years · Female only" }, "enrollment_count": 146, "start_date": "2020-06-12", "completion_date": "2021-12-15", "has_results": false, "last_update_posted_date": "2022-01-28", "last_synced_at": "2026-10-17T15:01:04.828Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT04305756" }, { "nct_id": "NCT04640181", "title": "Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "Enoxaparin", "type": "DRUG" }, { "name": "Rivaroxaban", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "St. David's HealthCare", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 150, "start_date": "2020-12-01", "completion_date": "2021-06-28", "has_results": false, "last_update_posted_date": "2021-06-30", "last_synced_at": "2026-10-17T15:01:04.828Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04640181" }, { "nct_id": "NCT00641732", "title": "Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Venous Thromboembolism" ], "interventions": [ { "name": "TAK-442", "type": "DRUG" }, { "name": "Enoxaparin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1045, "start_date": "2007-10", "completion_date": "2008-10", "has_results": false, "last_update_posted_date": "2016-04-13", "last_synced_at": "2026-10-17T15:01:04.828Z", "location_count": 38, "location_summary": "Birmingham, Alabama • Tuscaloosa, Alabama • Phoenix, Arizona + 35 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00641732" }, { "nct_id": "NCT02585713", "title": "Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cerebral Vein Thrombosis", "Deep Vein Thrombosis", "Gonadal Thrombosis", "Hepatic Thrombosis", "Malignant Neoplasm", "Mesenteric Thrombosis", "Metastatic Malignant Neoplasm", "Portal Vein Thrombosis", "Pulmonary Embolism", "Renal Vein Thrombosis", "Splenic Thrombosis", "Venous Thromboembolism" ], "interventions": [ { "name": "Apixaban", "type": "DRUG" }, { "name": "Dalteparin", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Academic and Community Cancer Research United", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2015-11-20", "completion_date": "2019-12-24", "has_results": true, "last_update_posted_date": "2020-08-04", "last_synced_at": "2026-10-17T15:01:04.828Z", "location_count": 18, "location_summary": "Scottsdale, Arizona • Jacksonville, Florida • Evanston, Illinois + 15 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Evanston", "state": "Illinois" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT02585713" }, { "nct_id": "NCT02704052", "title": "Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Deep Venous Thrombosis", "Pulmonary Embolus", "Venous Thromboembolism" ], "interventions": [ { "name": "Real time enoxaparin dose adjustment", "type": "DRUG" }, { "name": "Standard enoxaparin dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 116, "start_date": "2016-03", "completion_date": "2018-10", "has_results": false, "last_update_posted_date": "2019-05-24", "last_synced_at": "2026-10-17T15:01:04.828Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT02704052" }, { "nct_id": "NCT01014403", "title": "Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Venous Thromboembolism", "Traumatic Brain Injury" ], "interventions": [ { "name": "enoxaparin", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 62, "start_date": "2009-11", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2021-01-13", "last_synced_at": "2026-10-17T15:01:04.828Z", "location_count": 2, "location_summary": "Dallas, Texas • Tyler, Texas", "locations": [ { "city": "Dallas", "state": "Texas" }, { "city": "Tyler", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01014403" } ] }